Evidence map›Paper›PMID 21527497›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2011

Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance.

Katherine L Gross, Robert H Oakley, Alyson B Scoltock, Christine M Jewell, John A Cidlowski

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Glucocorticoid therapy in assisted reproduction.Clinical and experimental reproductive medicine · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The effects of microRNAs on glucocorticoid responsiveness.Journal of cancer research and clinical oncology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Corticosteroids: Mechanisms of Action in Health and Disease.Rheumatic diseases clinics of North America · 2016
    Review
  17. Specificity and sensitivity of glucocorticoid signaling in health and disease.Best practice & research. Clinical endocrinology & metabolism · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katherine L GrossMolecular Endocrinology Group, Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.
Robert H Oakley
Alyson B Scoltock
Christine M Jewell
John A Cidlowski
National Institutes of Health · USNational Institute of Environmental Health Sciences · US

Funding

Glucocorticoid Hormone ActionZIAES090057 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CIDLOWSKI, JOHN A. · 2009 to 2025
$44.9M
Intramural NIH HHS
6 · The paper itself

Abstract

Glucocorticoids regulate a variety of physiological processes and are commonly used to treat disorders of inflammation, autoimmune diseases, and cancer. Glucocorticoid action is predominantly mediated through the classic glucocorticoid receptor (GR)α isoform. Recent data suggest that the mature GRα mRNA is translated into multiple N-terminal isoforms that have distinct biochemical properties and gene regulatory profiles. Interestingly, osteosarcoma cells stably expressing the GRα-D translational isoform are unique in that they are resistant to glucocorticoid-induced apoptosis. In this study, we investigate whether GRα isoform-specific differences in the regulation of antiapoptotic genes contribute to this resistant phenotype. We now show that GRα-D, unlike the other receptor isoforms, does not inhibit the activity of a nuclear factor κB (NF-κB)-responsive reporter gene and does not efficiently repress either the transcription or protein production of the antiapoptotic genes Bcl-xL, cellular inhibitor of apoptosis protein 1, and survivin. The inability of GRα-D to down-regulate the expression of these genes appears to be associated with a diminished interaction between GRα-D and NF-κB that is observed in cells, but not in vitro, and likely reflects the sequestration of GRα-D in the nucleus. Deletion of the GRα N-terminal amino acids 98-335 also results in a nuclear resident GR, which fails to interact with NF-κB in cells and promote apoptosis in response to glucocorticoids. These data suggest that the N-terminal translational isoforms of GRα selectively regulate antiapoptotic genes and that the GRα-D isoform may contribute to the resistance of certain cancer cells to glucocorticoid-induced apoptosis.

Indexed as

Drug Resistance, NeoplasmAmino Acid MotifsApoptosisbcl-X ProteinCaspasesCell Line, TumorDexamethasoneGenes, ReporterGlucocorticoidsHumansInhibitor of Apoptosis ProteinsLuciferases, RenillaNF-kappa BOsteosarcomaPromoter Regions, GeneticProtein BindingBCL2L1 protein, humanbcl-X ProteinBIRC5 protein, humanCaspasesDexamethasoneglucocorticoid receptor alphaGlucocorticoidsInhibitor of Apoptosis ProteinsLuciferases, RenillaNF-kappa BProtein IsoformsReceptors, GlucocorticoidSurvivin

Identifiers

PMID21527497
PMCPMC3125093
OpenAlexW2077803308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.